PATENT CLAIM ANALYSIS

Application Number: 15763626
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "210210"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , W 3 , W 4 , A 1 , and A 2  are as defined in the description. Medicinal products containing the same which are useful in treating cancer, neurodegenerative disorders and metabolic disorders.

Claim (Index 61):
The method according to  claim 60 , wherein the cancer is selected from acute megakaryoblastic leukaemia (AMKL), acute lymphoblastic leukaemia (ALL), ovarian cancer, pancreatic cancer, gastrointestinal stromal tumours (GIST), osteosarcoma (OS), colorectal carcinoma (CRC), neuroblastoma and glioblastoma.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.45714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16306941', '14435851', '14559294', '15247499', '15738186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7953888217415255
- 35 USC 102 Novelty (BERT): 0.524941544132256
- Combined Prediction Score: 0.7683440939805986
- Mean Citation Score: 314.096512
- Max Citation Score: 331.03336
- Similarity Product: 234.8653917245769

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test